Skip to Main Content
More Intelligent Procurement, Faster R&D

Go to Main Navigation

Pear Bio

Start a request
Year Established:
2017
Website:
pearbio.com
Headquarters:
London, , GB
Company Type:
New Startup (0-1M TTM Revenue)

Pear Bio is a computational biology company that has developed a functional precision medicine platform to guide therapy choice in cancer patients, based on growing patients’ tumors in a lab and performing therapy dosing on parallel microtumors to assess response.

The platform uses organ-on-a-chip and computer vision to measure cancer progression over time. Pear Bio cultures patient tumor samples and tests potential treatment options and combinations ex vivo. A proprietary computer vision/ML pipeline finds image-based spatial biomarkers in time-course 3D microscopy data of the patient tumor cultures. The platform has applications in drug development (including combination therapy screening) and clinical biomarkers.

Pear Bio can provide lab services including:
- Compound screening
- 3D image analysis/computer vision services
- Combination therapy synergy testing
- Drug translation services using primary tumors
- Clinical biomarkers and patient stratification

Site Badges
Laboratory Pear Bio Laboratory
Imperial College White City IHub 84 Wood Lane London, W12 0BZ United Kingdom
Headquarter Pear Bio
Imperial College White City IHub 84 Wood Lane London, W12 0BZ United Kingdom

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service